Prevention of Early-Onset Neonatal Group B Streptococcal Disease with Selective Intrapartum Chemoprophylaxis

Kenneth M. Boyer, Samuel P. Gotoff

New England Journal of Medicine · 1986 · 759 citations · 24 references

Concepts

TL;DR

Early‑onset neonatal group B streptococcal disease is primarily intrapartum in origin, with higher attack rates in infants of mothers who are prenatally colonized and have risk factors such as premature labor, prolonged rupture of membranes, or intrapartum fever. The study randomized 160 high‑risk women to receive selective intrapartum ampicillin prophylaxis to evaluate its effect on neonatal group B streptococcal colonization and disease. Selective intrapartum ampicillin reduced neonatal colonization from 51 % to 9 %, decreased multiple‑site colonization from 30 % to 4 %, eliminated bacteremia, and was well tolerated, supporting its use in high‑risk mothers. Published in N Engl J Med 1986; 314:1665–9.

Abstract

Most cases of neonatal group B streptococcal disease with early onset have an intrapartum pathogenesis. Attack rates are increased substantially in infants born to mothers with prenatal group B streptococcal colonization and various perinatal risk factors (premature labor, prolonged membrane rupture, or intrapartum fever). In a randomized controlled trial, we studied the effect of selective intrapartum prophylaxis with ampicillin in 160 such high-risk women. In infants born to mothers who received intravenous ampicillin during labor, as compared with controls who received no treatment, neonatal colonization with group B streptococci was present in 8 of 85 (9 percent) versus 40 of 79 (51 percent; P<0.001), colonization at multiple (≥3) sites was observed in 3 of 85 (4 percent) versus 24 of 79 (30 percent; P<0.001), and bacteremia occurred in none of 85 versus 5 of 79 (6 percent; P = 0.024). The side effects of ampicillin were limited to a single episode of urticaria in a mother who had no history of penicillin allergy. We conclude that intrapartum ampicillin prophylaxis in women with positive prenatal cultures for group B streptococci who have certain perinatal risk factors can prevent early-onset neonatal group B streptococcal disease. (N Engl J Med 1986; 314:1665–9.)

References

24